Want to see SE:ACOU full AI Analyst Report?

AcouSort AB (ACOU) Price & Analysis

0 Followers

ACOU Stock Chart & Stats

kr3.72

-kr0.07(-1.88%)

At close: Jul 27 4:00 PM EDT

kr3.72

-kr0.07(-1.88%)

Day’s Range― - ―

52-Week Rangekr2.03 - kr5.16

Previous CloseN/A

Volume11.66K

Average Volume (3M)29.24K

Market Cap

kr74.71M

Enterprise Valuekr75.16M

Total Cash (Recent Filing)kr14.57M

Total Debt (Recent Filing)kr0.00

Price to Earnings (P/E)―

Beta0.15

Next Earnings

Aug 26, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.49

Shares Outstanding21,163,902

10 Day Avg. Volume27,764

30 Day Avg. Volume29,240

Financial Highlights & Ratios

PEG Ratio0.12

Price to Book (P/B)3.27

Price to Sales (P/S)7.79

P/FCF Ratio-3.09

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.3

Revenue Forecast (FY)kr10.70M

Bulls Say, Bears Say

Bulls Say

Debt-free Balance SheetThe company’s zero-debt capital structure materially reduces solvency risk and preserves financing optionality. Over a multi-quarter horizon this conservatism supports continued R&D and commercialization without interest burdens, giving operational flexibility during cash burn.

Improving Revenue TrendImproving TTM revenue demonstrates growing market adoption of AcouSort’s offerings and provides a foundation to scale fixed-cost absorption. If sustained, this top-line momentum can enable progressive margin recovery and a clearer path toward break-even over several quarters.

Proprietary Acoustic Separation TechAcouTrap’s label-free, gentle acoustic separation is a specialized platform well-suited for sample prep and cell-therapy workflows. This differentiated, application-focused technology represents a durable competitive asset that supports integration into diagnostics and cell‑therapy value chains.

Bears Say

Negative Gross Profit & Persistent LossesNegative gross profit and sustained operating/net losses show core unit economics are not yet viable. Over multiple quarters this undercuts margin sustainability, limits reinvestment capacity, and requires material improvement in product economics to avoid ongoing capital drains.

Negative And Declining Cash FlowConsistently negative operating and free cash flow, including a steep FCF decline, indicate uneven and deteriorating cash generation. This pattern heightens reliance on external funding, increases dilution or refinancing risk, and constrains multi-quarter investment in commercialization and R&D.

Eroding Equity & Poor ReturnsA ~-80% TTM ROE and shrinking equity indicate losses are eroding shareholder capital and internal funding capacity. Persisting this trend raises the prospect of recapitalization, weakens financial resilience, and pressures management to secure durable capital solutions.

ACOU FAQ

What was AcouSort AB’s price range in the past 12 months?

AcouSort AB lowest stock price was kr2.03 and its highest was kr5.16 in the past 12 months.

What is AcouSort AB’s market cap?

AcouSort AB’s market cap is kr74.71M.

When is AcouSort AB’s upcoming earnings report date?

AcouSort AB’s upcoming earnings report date is Aug 26, 2026 which is in 19 days.

How were AcouSort AB’s earnings last quarter?

AcouSort AB released its earnings results on May 27, 2026. The company reported -kr0.112 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.112.

Is AcouSort AB overvalued?

According to Wall Street analysts AcouSort AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does AcouSort AB pay dividends?

AcouSort AB does not currently pay dividends.

What is AcouSort AB’s EPS estimate?

AcouSort AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does AcouSort AB have?

AcouSort AB has 21,163,902 shares outstanding.

What happened to AcouSort AB’s price movement after its last earnings report?

AcouSort AB reported an EPS of -kr0.112 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.139%.

Which hedge fund is a major shareholder of AcouSort AB?

Currently, no hedge funds are holding shares in SE:ACOU

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

AcouSort AB

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy and other elements of the future automated systems. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden.